This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Complex Relationship Between Alcohol and Heart Health Alcohol and heart health have long been subjects of debate. Some studies suggest that moderate alcohol consumption may provide cardiovascular benefits, while excessive or binge drinking can significantly harm the heart. Understanding the effects of alcohol on heart disease, blood pressure, and heart muscle function is essential for making informed decisions about alcohol intake.
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
Our top 5 headlines featured an oral drug delivering 16% weight loss, notable blood pressure reductions from a hypertension treatment, and 3 key FDA decisions.
Panelists discuss recent advances in understanding the pathogenesis of generalized pustular psoriasis (GPP) and how these insights have influenced the approach to and management of the disease. They also outline their immediate and long-term treatment goals for patients with GPP, focusing on symptom control and long-term disease management.
Panelists discuss the general treatment approach for generalized pustular psoriasis (GPP) prior to the availability of FDA-approved agents with specific indications, examining how these treatments aligned with patient goals and identifying the unmet needs that remained in managing the disease.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content